SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-026717
Filing Date
2017-11-16
Accepted
2017-11-16 21:18:47
Documents
2
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3870
2 EX-24 DOCUMENT attachment1.htm EX-24 3507
  Complete submission text file 0000899243-17-026717.txt   8924
Mailing Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100
Business Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100 4540307375
Lundbeckfond Invest A/S (Reporting) CIK: 0001591046 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38293 | Film No.: 171209582

Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations